Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

BioMarin Pharmaceutical Inc. buy Truist Financial Co.

BioMarin Pharmaceutical Inc.
Start price
€76.16
13.07.23 / 50%
Target price
€125.20
13.07.24
Performance (%)
-0.50%
Price
€76.16
09.05.24
Summary
This prediction is currently active. Since the start of the prediction for BioMarin Pharmaceutical Inc. the price has only changed by -0.50%. This prediction currently runs until 13.07.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
BioMarin Pharmaceutical Inc. -2.509% -2.509%
iShares Core DAX® 4.015% 2.971%
iShares Nasdaq 100 2.755% 0.503%
iShares Nikkei 225® -0.826% -5.057%
iShares S&P 500 2.330% 0.720%

Comments by Truist_Financial_Co_ for this prediction

In the thread BioMarin Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -0.50%
Target price 125.202
Change
Ends at 13.07.24

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target raised by analysts at Truist Financial Co. from $125.00 to $140.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat

Truist Financial Co. 
0
Report Share
13.07.23

Stopped prediction by Truist_Financial_Co_ for BioMarin Pharmaceutical Inc.

buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€83.00
25.09.23
€131.92
25.09.24
-8.24%
09.05.24

Truist Financial Co. 
25.09.23 50%
buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€82.68
15.09.23
€131.12
15.09.24
-7.89%
09.05.24

Truist Financial Co. 
15.09.23 50%